Almirall, S.A. (BME:ALM) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year
Nov 14
Have your own idea? Try our Stock Screener
Spanish (IBEX) Pharma Industry Analysis
UpdatedNov 24, 2024
DataAggregated Company Financials
Companies5
- 7D0.8%
- 3M-11.8%
- 1Y9.6%
- YTD2.8%
The Pharma industry has stayed flat over the last week. The past year has been better, since the industry has gained 9.6% in that time. Earnings are forecast to grow by 26% annually.
Industry Valuation and Performance
Has the Spanish Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Mon, 25 Nov 2024 | €6.3b | €2.7b | €226.1m | 19.5x | 28.1x | 2.4x |
| Wed, 23 Oct 2024 | €7.3b | €2.5b | €219.5m | 26.5x | 33.2x | 2.9x |
| Fri, 20 Sep 2024 | €7.1b | €2.5b | €219.5m | 23.6x | 32.2x | 2.8x |
| Sun, 18 Aug 2024 | €7.1b | €2.5b | €219.5m | 23.7x | 32.5x | 2.8x |
| Tue, 16 Jul 2024 | €7.7b | €2.5b | €202.7m | 24x | 37.8x | 3.1x |
| Thu, 13 Jun 2024 | €8.0b | €2.5b | €202.7m | 27.2x | 39.4x | 3.2x |
| Sat, 11 May 2024 | €7.6b | €2.5b | €194.0m | 23x | 39.1x | 3x |
| Mon, 08 Apr 2024 | €7.1b | €2.6b | €223.6m | 21.2x | 31.9x | 2.8x |
| Wed, 06 Mar 2024 | €6.7b | €2.6b | €223.6m | 20.9x | 30x | 2.6x |
| Fri, 02 Feb 2024 | €6.3b | €2.6b | €295.8m | 16.7x | 21.3x | 2.4x |
| Sun, 31 Dec 2023 | €6.2b | €2.6b | €296.4m | 15.7x | 20.8x | 2.4x |
| Tue, 28 Nov 2023 | €5.9b | €2.6b | €296.4m | 15.6x | 19.9x | 2.3x |
| Thu, 26 Oct 2023 | €5.6b | €2.5b | €274.5m | 14.2x | 20.3x | 2.2x |
| Sat, 23 Sep 2023 | €5.9b | €2.5b | €274.5m | 15x | 21.6x | 2.4x |
| Mon, 21 Aug 2023 | €5.7b | €2.5b | €274.5m | 13.8x | 20.8x | 2.3x |
| Wed, 19 Jul 2023 | €4.8b | €2.4b | €284.3m | 11.1x | 17x | 2x |
| Fri, 16 Jun 2023 | €4.9b | €2.4b | €284.3m | 11.7x | 17.4x | 2x |
| Sun, 14 May 2023 | €5.1b | €2.4b | €289.9m | 11.4x | 17.5x | 2.1x |
| Tue, 11 Apr 2023 | €5.0b | €2.4b | €301.6m | 17.4x | 16.5x | 2.1x |
| Thu, 09 Mar 2023 | €5.0b | €2.4b | €301.6m | 18.1x | 16.6x | 2.1x |
| Sat, 04 Feb 2023 | €5.1b | €2.3b | €275.8m | 30x | 18.4x | 2.2x |
| Mon, 02 Jan 2023 | €4.8b | €2.3b | €275.8m | 26.2x | 17.5x | 2.1x |
| Wed, 30 Nov 2022 | €4.9b | €2.3b | €275.8m | 31.2x | 17.9x | 2.1x |
| Fri, 28 Oct 2022 | €5.4b | €2.3b | €306.3m | 23.1x | 17.8x | 2.3x |
| Sun, 25 Sep 2022 | €5.2b | €2.3b | €306.3m | 24.2x | 17x | 2.3x |
| Tue, 23 Aug 2022 | €6.0b | €2.3b | €306.3m | 27.6x | 19.7x | 2.6x |
| Thu, 21 Jul 2022 | €6.6b | €2.3b | €225.4m | 17.6x | 29.3x | 2.9x |
| Sat, 18 Jun 2022 | €6.2b | €2.3b | €225.4m | 17x | 27.7x | 2.8x |
| Mon, 16 May 2022 | €6.6b | €2.2b | €200.5m | 21.3x | 32.7x | 3x |
| Wed, 13 Apr 2022 | €7.2b | €2.1b | €200.5m | 23.7x | 36x | 3.4x |
| Fri, 11 Mar 2022 | €7.1b | €2.1b | €200.5m | 25.2x | 35.6x | 3.3x |
| Sun, 06 Feb 2022 | €7.0b | €2.0b | €177.1m | 32.9x | 39.4x | 3.4x |
| Tue, 04 Jan 2022 | €7.3b | €2.0b | €177.1m | 35.5x | 41x | 3.5x |
| Thu, 02 Dec 2021 | €6.9b | €2.0b | €188.4m | 32.5x | 36.4x | 3.4x |
Price to Earnings Ratio
36.4x
Current Industry PE
- Investors are relatively neutral on the Spanish Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 26.4x.
- The industry is trading close to its 3-year average PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 13% per year over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Spanish Healthcare industry?
| ES Market | 0.36% | |
| Healthcare | -2.01% | |
| Pharma | 0.76% | |
| Pharma | 0.76% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ROVI Laboratorios Farmaceuticos Rovi | €63.00 | 1.4% +€43.5m | 14.3% | PE19.5x | |
| ALM Almirall | €8.47 | 1.3% +€23.5m | 1.4% | PS1.9x |
